- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vestibular Rehabilitation in the ED: Pilot Study Highlights Potential Benefits for Dizziness and Vertigo

USA: A recent nonrandomized clinical trial has assessed the feasibility and impact of vestibular rehabilitation therapy (VRT) for patients presenting to the emergency department (ED) with dizziness and vertigo.
The researchers found that vestibular therapy was successfully administered in the ED to patients with undifferentiated dizziness symptoms. However, they note that among those who received the treatment, the changes in dizziness-related disability over three months were not statistically significant, highlighting the need for a larger randomized clinical trial to assess its effectiveness comprehensively.
The findings were published online in JAMA Network Open on February 14, 2025.
The researchers note that dizziness symptoms contribute to nearly 2 million emergency department visits yearly, posing a significant diagnostic challenge for clinicians. While most research in this area has focused on enhancing guideline-based care, there has been limited emphasis on patient-centered interventions for reducing dizziness-related disability. In this context, Howard S. Kim, Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, and colleagues aimed to evaluate the feasibility of implementing emergency department vestibular rehabilitation therapy (ED-VeRT). Using a structured diagnostic classification algorithm, the study assessed the delivery of vestibular therapy in the ED and tracked patient-reported outcomes over time to determine its impact on dizziness-related disability.
For this purpose, the researchers conducted a pilot nonrandomized clinical trial at a single urban US emergency department from 2021 to 2023, with three-month outcome collection until May 1, 2023. Patients with dizziness were assigned to ED-VeRT or usual care based on physician discretion. A physical therapist administered ED-VeRT using a structured diagnostic and treatment algorithm. Feasibility outcomes included screening, enrollment, and retention rates, while efficacy was assessed through changes in the Dizziness Handicap Inventory and Vestibular Activities Avoidance Inventory-9 scores over three months.
The study led to the following findings:
- Three-hundred sixty-six patients were screened, and 125 participants were enrolled (median age: 52 years). Among the participants, 73 (58%) were female, and 61 (49%) identified as White.
- Longitudinal data collection retained 84.0% of participants.
- ED vestibular therapy was received by 50.4% of participants.
- Primary diagnostic classifications included benign paroxysmal positional vertigo (37.1% participants), triggered undifferentiated dizziness (22.6% participants), spontaneous undifferentiated dizziness (22.6% participants), and unilateral peripheral hypofunction (14.5% participants).
- Although ED-VeRT participants had higher baseline dizziness-related disability scores, they reported lower dizziness handicap (-1.68) and vestibular activities avoidance (-2.27) at three months, but these differences were not statistically significant.
"The pilot nonrandomized clinical trial explored the feasibility of providing vestibular rehabilitation therapy in the emergency department using a standardized diagnostic system. It also gathered initial data on patient-reported outcomes over three months. The results highlight the need for a larger, fully powered randomized clinical trial to evaluate the effectiveness of ED vestibular therapy," the researchers concluded.
Reference:
Kim HS, Schauer JM, Kan AK, et al. Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo: A Nonrandomized Clinical Trial. JAMA Netw Open. 2025;8(2):e2459567. doi:10.1001/jamanetworkopen.2024.59567
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751